EUVIMEDEUVIMED entdecken
Open Access

Limited Sampling Strategies to Predict Ganciclovir Exposure after Valganciclovir Administration and to Reduce Monitoring Constraints in Renal Transplant Children

A Facchin iD, N Benyoub, V Elie, S Magreault, E Jacqz-Aigrain

Antimicrobial Agents and Chemotherapy · 2023

DOI: 10.1128/aac.01597-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von A Facchin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Pharmacology and Pharmacogenetics, Hôpital Robert Debré, Assistance Publique - Hôpitaux de Paris, Paris, France. Hauptthemen laut MEDLINE: Kidney Transplantation, Cytomegalovirus Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Valganciclovir, the ganciclovir prodrug, is an antiviral agent used to prevent cytomegalovirus infection in renal transplant children. Therapeutic drug monitoring is still necessary to ensure optimal therapeutic area under the concentration-time curve from 0 to 24 h (AUC 0–24 ) of 40 to 60 μg·h/mL since valganciclovir presents a high pharmacokinetic variability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationCytomegalovirus InfectionsHumansChildValganciclovirGanciclovirRetrospective StudiesAntiviral Agents

Stichwörter der Autor:innen

limited sampling strategypediatric kidney transplantationtherapeutic drug monitoringvalganciclovir

Substanzen

ValganciclovirGanciclovirAntiviral Agents

Autor:innen und Institutionen

  • Department of Paediatric Pharmacology and Pharmacogenetics, Hôpital Robert Debré, Assistance Publique - Hôpitaux de Paris, Paris, France.
  • Service of Pharmacy, Centre Hospitalier Intercommunal Nord Ardennes, Charleville-Mézières, France.
  • University Paris -Cité, Paris, France.

ORCID-Profile: A Facchin

Zitieren

APA

Facchin, A., Benyoub, N., Elie, V., Magreault, S., & Jacqz-Aigrain, E. (2023). Limited Sampling Strategies to Predict Ganciclovir Exposure after Valganciclovir Administration and to Reduce Monitoring Constraints in Renal Transplant Children. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01597-22

Vancouver

Facchin A, Benyoub N, Elie V, Magreault S, Jacqz-Aigrain E. Limited Sampling Strategies to Predict Ganciclovir Exposure after Valganciclovir Administration and to Reduce Monitoring Constraints in Renal Transplant Children. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.01597-22

BibTeX
@article{Facchin2023,
  author = {Facchin, A and Benyoub, N and Elie, V and Magreault, S and Jacqz-Aigrain, E},
  title = {Limited Sampling Strategies to Predict Ganciclovir Exposure after Valganciclovir Administration and to Reduce Monitoring Constraints in Renal Transplant Children},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2023},
  doi = {10.1128/aac.01597-22}
}
Kostenlos starten →